Juno Therapeutics Inc. (JUNO) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Juno Therapeutics Inc. (JUNO)

An SI Board Since May 2015

Posts	SubjectMarks	Bans	Symbol
84	19	0	JUNO

Emcee: scaram(o)uche	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
59	I was too stingy this am in pre-market, as I was sweating the pennies. Finally	Biotech Jim	-	3/2/2017
58	Trying to pick up shares pre-market, but no many sellers. Very interesting conf	Biotech Jim	-	3/2/2017
57	I need to clarify one thing in the quickly typed note. Dr. Bloom was Head of R&	Biotech Jim	-	3/1/2017
56	I was hoping that JCAR015 would be terminated, as why waste $$ on an inferior co	Biotech Jim	1	3/1/2017
55	And now they've ditched the program. Actually, that makes sense, given the	tuck	-	3/1/2017
54	>> informed consent of this extreme nature is countered by the chance for	scaram(o)uche	-	2/28/2017
53	kite.... Message 31006812 and on topic...... Message 30998475 Please follow	scaram(o)uche	-	2/28/2017
52	Tuck, this is quite helpful. thanks for digging and posting. i decided to hol	mopgcw	-	11/30/2016
51	What if JUNO tried lower dose preconditioning a la KITE? RBC note on difference	tuck	-	11/24/2016
50	I was talking a much longer time frame. blcm comes to mind, if you like the GvH	scaram(o)uche	-	11/23/2016
49	Well, we got that.Yup. Luckily for me, my sold puts expired worthless a few day	tuck	-	11/23/2016
48	and here's the latest wrinkle on ablation with ganciclovir...... Mol Imagin	scaram(o)uche	-	11/23/2016
47	Well, we got that. Ugh. Ugh, ugh, ugh, ugh. I am, however, surprised at the b	scaram(o)uche	-	11/23/2016
46	Juno Therapeutics plunges as much as 44% after study kills another patient cnb	Julius Wong	-	11/23/2016
45	In the hopes of a fairly quick buck - but OK if not - sold some ATM Oct puts jus	tuck	-	10/12/2016
44	No. There is a Chinese trial, simultaneously testing CD19- and CD20-specific	scaram(o)uche	-	9/28/2016
43	i see no reason to bail here, do you?	mopgcw	-	9/28/2016
42	jci.org pointer from Biomaven, perhaps of interest in juno/kite light.	scaram(o)uche	-	9/27/2016
41	And 20%, my perspective, would be excellent. (given SAEs that are generally man	scaram(o)uche	-	9/26/2016
40	one guess (given 3 month of 33%)...... User Actions Following [graphic]JQ?@jq	scaram(o)uche	-	9/26/2016
39	kite.... Small number of retreated patients not included in today's data	scaram(o)uche	-	9/26/2016
38	kite top line looks very good. Lots of twitter chatter about erosion of CR rate	scaram(o)uche	-	9/26/2016
37	This will get interesting with Novartis news of folding their program, a bumpy r	mopgcw	-	9/1/2016
36	J Clin Invest. 2016 Aug 29. pii: 87366. doi: 10.1172/JCI87366. [Epub ahead of pr	scaram(o)uche	-	8/31/2016
35	Rocket trial resumed.... ir.junotherapeutics.com	mopgcw	-	7/12/2016

Go to reply# or date (mm/dd/yy):